BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 25776032)

  • 1. Practical approaches for design and analysis of clinical trials of infertility treatments: crossover designs and the Mantel-Haenszel method are recommended.
    Takada M; Sozu T; Sato T
    Pharm Stat; 2015; 14(3):198-204. PubMed ID: 25776032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and analysis of crossover trials for absorbing binary endpoints.
    Nason M; Follmann D
    Biometrics; 2010 Sep; 66(3):958-65. PubMed ID: 19930189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Planning and analysis of cross-over trials in infertility.
    Makubate B; Senn S
    Stat Med; 2010 Dec; 29(30):3203-10. PubMed ID: 21170914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Empirical evidence of bias in infertility research: overestimation of treatment effect in crossover trials using pregnancy as the outcome measure.
    Khan KS; Daya S; Collins JA; Walter SD
    Fertil Steril; 1996 May; 65(5):939-45. PubMed ID: 8612853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cluster randomised crossover trials with binary data and unbalanced cluster sizes: application to studies of near-universal interventions in intensive care.
    Forbes AB; Akram M; Pilcher D; Cooper J; Bellomo R
    Clin Trials; 2015 Feb; 12(1):34-44. PubMed ID: 25475880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A practical Bayesian stepped wedge design for community-based cluster-randomized clinical trials: The British Columbia Telehealth Trial.
    Cunanan KM; Carlin BP; Peterson KA
    Clin Trials; 2016 Dec; 13(6):641-650. PubMed ID: 27430710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statistical methods for the meta-analysis of cluster randomization trials.
    Donner A; Piaggio G; Villar J
    Stat Methods Med Res; 2001 Oct; 10(5):325-38. PubMed ID: 11697225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal and repeated cross-sectional cluster-randomization designs using mixed effects regression for binary outcomes: bias and coverage of frequentist and Bayesian methods.
    Localio AR; Berlin JA; Have TR
    Stat Med; 2006 Aug; 25(16):2720-36. PubMed ID: 16345043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crossover or parallel design in infertility trials? The discussion continues.
    Cohlen BJ; te Velde ER; Looman CW; Eijckemans R; Habbema JD
    Fertil Steril; 1998 Jul; 70(1):40-5. PubMed ID: 9660418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomization model methods for evaluating treatment efficacy in multicenter clinical trials.
    Davis CS; Chung Y
    Biometrics; 1995 Sep; 51(3):1163-74. PubMed ID: 7548700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weighted re-randomization tests for minimization with unbalanced allocation.
    Han B; Yu M; McEntegart D
    Pharm Stat; 2013; 12(4):243-53. PubMed ID: 23760923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Odds ratio for 2 × 2 tables: Mantel-Haenszel estimator, profile likelihood, and presence of surrogate responses.
    Banerjee B; Biswas A
    J Biopharm Stat; 2014; 24(3):649-59. PubMed ID: 24697719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The place of the crossover design in infertility trials: a maximum likelihood approach.
    McDonnell J; Goverde AJ; Vermeiden JP
    Hum Reprod; 2004 Nov; 19(11):2537-44. PubMed ID: 15459169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of trial design on the estimation of drug potency and power in clinical trials of haemophilia with inhibitors.
    Larsen MS; Juul RV; Kreilgaard M; Kristensen AT; Simonsson USH
    Eur J Pharm Sci; 2018 Oct; 123():531-538. PubMed ID: 30077714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence from crossover trials: empirical evaluation and comparison against parallel arm trials.
    Lathyris DN; Trikalinos TA; Ioannidis JP
    Int J Epidemiol; 2007 Apr; 36(2):422-30. PubMed ID: 17301102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of baseline covariates on the efficiency of statistical analyses of crossover designs.
    Yan Z
    Stat Med; 2013 Mar; 32(6):956-63. PubMed ID: 22903413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accounting for centre-effects in multicentre trials with a binary outcome - when, why, and how?
    Kahan BC
    BMC Med Res Methodol; 2014 Feb; 14():20. PubMed ID: 24512175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothesis testing and estimation in ordinal data under a simple crossover design.
    Lui KJ; Chang KC
    J Biopharm Stat; 2012; 22(6):1137-47. PubMed ID: 23075013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and analysis of experiments.
    Shuster JJ
    Methods Mol Biol; 2007; 404():235-59. PubMed ID: 18450053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.